Independent oncogenic and therapeutic significance of phosphatase PRL-3 in FLT3-ITD–negative acute myeloid leukemia

Author： Qu Shuang   Liu Bin   Guo Xiaoling   Shi Hongshun   Zhou Meifeng   Li Li   Yang Shulan   Tong Xiuzhen   Wang Haihe  

Publisher： Blackwell Publishing

E-ISSN： 1097-0142|120|14|2130-2141

ISSN： 0008-543X

Source： Cancer, Vol.120, Iss.14, 2014-07, pp. : 2130-2141

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

FLT3 and Acute Myelogenous Leukemia: Biology, Clinical Significance and Therapeutic Applications

By  

Current Pharmaceutical Design, Vol. 11, Iss. 26, 2005-10 ,pp. : 3449-3457

Bentham Science Publishers

Access to resources Recommend Favorite

FLT3 as a Therapeutic Target in Childhood Acute Leukemia

By  

Current Drug Targets, Vol. 8, Iss. 6, 2007-06 ,pp. : 703-714

Bentham Science Publishers

Access to resources Recommend Favorite

The clinical development of FLT3 inhibitors in acute myeloid leukemia

By Knapper Steven  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 10, 2011-10 ,pp. : 1377-1395

Informa Healthcare

Access to resources Recommend Favorite

Treatment with FLT3 inhibitor in patients with FLT3-mutated acute myeloid leukemia is associated with development of secondary FLT3–tyrosine kinase domain mutations

By Alvarado Yesid   Kantarjian Hagop M.   Luthra Rajyalakshmi   Ravandi Farhad   Borthakur Gautam   Garcia-Manero Guillermo   Konopleva Marina   Estrov Zeev   Andreeff Michael   Cortes Jorge E.  

Cancer, Vol. 120, Iss. 14, 2014-07 ,pp. : 2142-2149

Blackwell Publishing

Access to resources Recommend Favorite

Pgp and FLT3: Identification and Modulation of Two Proteins that Lead to Chemotherapy Resistance in Acute Myeloid Leukemia

By  

Current Medicinal Chemistry, Vol. 14, Iss. 5, 2007-02 ,pp. : 519-530

Bentham Science Publishers

Access to resources Recommend Favorite